ASH1L and posterior cortical atrophy: Next, we introduced ASH1L-F3 into LNCaP (a PCa cell line with low metastatic potential and low expression of ASH1L) and confirmed its histone methyltransferase activity at H3K36 and H3K4 (Fig. 1i).